** = Publikationen gelistet in SCI/SSCI/Pubmed
** Svehlikova, E; Arfelt, KN; Cailleteau, R; Deller, S; Thomsen, KMD; Hart, M; Mursic, I; Pieber, TR; Haahr, H
Hypoglycaemia frequency and physiological response to double or triple doses of once weekly insulin icodec vs. once-daily insulin glargine U100 in type 2 diabetes
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):262-263.-50. ÖDG Jahrestagung; NOV 17-19, 2022; Salzburg, Austria.
[Poster]
Web of Science
** Heise, T; Korsatko, S; Nosek, L; Coester, HV; Deller, S; Roepstorff, C; Segel, S; Kapur, R; Haahr, H; Hompesch, M
Steady state is reached within 2-3 days of once-daily administration of degludec, a basal insulin with an ultralong duration of action.
J Diabetes. 2016; 8(1):132-138
Doi: 10.1111/1753-0407.12266
Web of Science
PubMed
FullText
FullText_MUG
** Pieber, TR; Deller, S; Korsatko, S; Jensen, L; Christiansen, E; Madsen, J; Heller, SR
Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial.
Diabetes Obes Metab. 2015; 17(8):742-750
Doi: 10.1111/dom.12473
Web of Science
PubMed
FullText
FullText_MUG
** Korsatko, S; Deller, S; Mader, JK; Glettler, K; Koehler, G; Treiber, G; Urschitz, M; Wolf, M; Hastrup, H; Søndergaard, F; Haahr, H; Pieber, TR
Ultra-long pharmacokinetic properties of insulin degludec are comparable in elderly subjects and younger adults with type 1 diabetes mellitus.
Drugs Aging. 2014; 31(1):47-53
Doi: 10.1007/s40266-013-0138-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Greiner, H; Schaller-Ammann, R; Huber, A; O'Connell, M; Krejci, J; Porro, G; Korsatko, S; Gurban, J; Deller, S; Brunner, M; Berghofer, A; Priedl, J; Zijlstra, E; Heise, T; Pieber, TR; Schaupp, L
Continuous Blood Glucose Monitoring (Cgm) System Based on Intravenous Microdialysis and Glucose Sensing.
Biomed Tech (Berl). 2013; 58 Suppl 1:
Doi: 10.1515/bmt-2013-4224
Web of Science
PubMed
FullText
FullText_MUG
** Korsatko, S; Deller, S; Koehler, G; Mader, JK; Neubauer, K; Adrian, CL; Thomsen, H; Haahr, H; Pieber, TR
A comparison of the steady-state pharmacokinetic and pharmacodynamic profiles of 100 and 200 U/mL formulations of ultra-long-acting insulin degludec.
Clin Drug Investig. 2013; 33(7):515-521
Doi: 10.1007/s40261-013-0096-7
Web of Science
PubMed
FullText
FullText_MUG
** Mader, JK; Birngruber, T; Korsatko, S; Deller, S; Köhler, G; Boysen, S; Augustin, T; Mautner, SI; Sinner, F; Pieber, TR; AP@home Consortium
Enhanced absorption of insulin aspart as the result of a dispersed injection strategy tested in a randomized trial in type 1 diabetic patients.
Diabetes Care. 2013; 36(4):780-785
Doi: 10.2337/dc12-1319
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pieber, TR; Deller, S; Brunner, M; Jensen, L; Christiansen, E; Kiyomi, F; Heller, SR
Treatment with liraglutide as adjunct to insulin in type 1 diabetes; effects on counter regulatory response to hypoglycaemia: a randomised, double blind, crossover trial
DIABETOLOGIA. . 2013; 56: S404-S405.-49th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 23-27, 2013; Barcelona, SPAIN.
[Poster]
Web of Science
** Schaller-Ammann, R; Greiner, H; Huber, A; O'Connell, M; Krejci, J; Porro, G; Korsatko, S; Gurban, J; Deller, S; Brunner, M; Berghofer, A; Priedl, J; Zijlstra, E; Heise, T; Pieber, TR; Schaupp, L;
CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEM USING INTRAVENOUS MICRODIALYSIS AND GLUCOSE SENSING.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A72-A72. NEW ROCHELLE: MARY ANN LIEBERT INC;
[Poster]
Web of Science
** Ribitsch, D; Heumann, S; Trotscha, E; Herrero Acero, E; Greimel, K; Leber, R; Birner-Gruenberger, R; Deller, S; Eiteljoerg, I; Remler, P; Weber, T; Siegert, P; Maurer, KH; Donelli, I; Freddi, G; Schwab, H; Guebitz, GM
Hydrolysis of polyethyleneterephthalate by p-nitrobenzylesterase from Bacillus subtilis.
Biotechnol Prog. 2011; 27(4):951-960
Doi: 10.1002/btpr.610
Web of Science
PubMed
FullText
FullText_MUG
** Deller, S; Neubauer, K; Korsatko, S; Wolf, M; Urschitz, M; Zahiragic, S; Mader, J; Adrian, C; Thomsen, H; Haahr, H; Pieber, T
Ultra-Long-acting insulin Degludec: Two different concentrations (U100 and U200) showing bioequivalence and comparable pharmacodynamics
WIEN KLIN WOCHENSCHR. . 2011; 123: S10-S11.-39. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 17-19, 2011; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
** Kohler, G; Korsatko, S; Deller, S; Neubauer, K; Bock, G; Mader, J; Roepstorff, C; Rasmussen, S; Haahr, H; Pieber, T; Heller, S
Induced hypoglycemia in type 1 diabetes with insulin Degludev and Insulin Glargine
WIEN KLIN WOCHENSCHR. 2011; 123: S9-S9.-ÖDG; NOV 17-19, 2011; Salzburg, Austria.
[Oral Communication]
Web of Science
** Deller, S; Mascher, F; Platzer, S; Reinthaler, FF; Marth, E
Effect of solar radiation on survival of indicator bacteria in bathing waters.
Central European journal of public health. 2006; 14(3): 133-137.
Doi: 10.21101/cejph.a3380
PubMed
FullText
FullText_MUG
** Mascher, F; Deller, S; Pichler-Semmelrock, FP; Roehm, S; Marth, E
The significance of sunlight for the elimination of indicator bacteria in small-scale bathing ponds in central Europe.
Water Sci Technol. 2003; 47(3):211-213
Doi: 10.2166/wst.2003.0197
Web of Science
PubMed
FullText
FullText_MUG